BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18669177)

  • 1. Microvascular network in renal carcinomas. Quantitative and tissue microarray immunohistochemical study.
    Okoń K; Kawa R
    Pol J Pathol; 2008; 59(2):107-15. PubMed ID: 18669177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
    Mertz KD; Demichelis F; Kim R; Schraml P; Storz M; Diener PA; Moch H; Rubin MA
    Hum Pathol; 2007 Oct; 38(10):1454-62. PubMed ID: 17889675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
    Chang BD; Cao LS; Zhou HL
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications.
    Yao X; Qian CN; Zhang ZF; Tan MH; Kort EJ; Yang XJ; Resau JH; Teh BT
    Clin Cancer Res; 2007 Jan; 13(1):161-9. PubMed ID: 17200351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels.
    Ruiz-Saurí A; García-Bustos V; Granero E; Cuesta S; Sales MA; Marcos V; Llombart-Bosch A
    Pathol Oncol Res; 2018 Jul; 24(3):515-524. PubMed ID: 28669081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 is expressed in chromophobe renal cell carcinomas.
    Okoń K
    Pol J Pathol; 2008; 59(1):15-20. PubMed ID: 18655366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractal dimension of microvasculature in renal oncocytomas and chromophobe renal cell carcinomas.
    Karslioğlu Y; Günal A; Kurt B; Ongürü O; Ozcan A
    Pathol Res Pract; 2009; 205(10):677-81. PubMed ID: 19362432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth inhibitor 174 is a negative regulator of aggressiveness and microvascular density in human clear cell renal cell carcinoma.
    Wu L; Li X; Ye L; Shayiremu D; Deng X; Zhang X; Jiang W; Yang Y; Gong K; Zhang N
    Anticancer Res; 2014 Feb; 34(2):715-22. PubMed ID: 24511004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
    Lin BT; Brynes RK; Gelb AB; McCourty A; Amin MB; Medeiros LJ
    Mod Pathol; 1998 Nov; 11(11):1075-81. PubMed ID: 9831205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma.
    Sabo E; Boltenko A; Sova Y; Stein A; Kleinhaus S; Resnick MB
    Clin Cancer Res; 2001 Mar; 7(3):533-7. PubMed ID: 11297244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin expression in normal kidney tissue and renal carcinomas.
    Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
    Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma.
    Imao T; Egawa M; Takashima H; Koshida K; Namiki M
    Int J Urol; 2004 Nov; 11(11):948-53. PubMed ID: 15509196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vitamin D3 receptor in kidney tumors.
    Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
    Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H
    Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.